Mebo International Group (China)

Company Description

MEBO INTERNATIONAL GROUP was founded in 1987. It is the only high tech industry group engaging in R&D of tissue organ in situ regenerative medicine and high tech products for commerce, technology and capital management.

Twenty first century is the era of life science. MEBO INTERNATIONAL GROUP achieves unprecedented progress in exploring mysteries of life continuation and human health, and tries hard to explain secrets of life science. Completely different from the antagonistic thought of western medicine by tracing life origin and genetic materials to treat diseases, MEBO scientific researchers, LED by our pioneering, professor Rongxiang Xu, utilize the regenerative potentiality of adult tissue cell to in situ regenerate and repair the damaged tissue organs by way of activating, proliferating, and directionally differentiating potential regenerative cells (PRCs), meanwhile, provide physiologically moist environment and required nutrition to realize in situ regeneration and reparation of damaged tissue organs. This is a revolutionary achievement, and a significant milestone of life science. The first breakthrough is the skin tissue organ regenerative technique and product ---- MEBO Moist Exposed Burn Ointment. This technique can not only save the lives of the burn patients, but also achieve perfect efficacies-the patients healed without scar formation. This is firstly that human being can directly benefit from the clinical achievements of regenerative medicine.

Based on the model of skin regenerative technology, another achievement of regenerative medicine, gastrointestinal mucosa regeneration and its product-MEBO Gastrointestinal Capsule succeeds. Additionally, the research of the 55 tissue organs regeneration, such as pancreatic gland, cardiac muscle, marrow, nerves and hair follicle etc, has achieved delectable progress. It can be predicted that more and more MEBO functional regenerative products will go on the market. MEBO serial regenerative technologies and products can make significant contribution to human health, disease elimination and long life, and its achievements had received more than 10 patents in China, USA, Europe and Japan.

MEBO INTERNATIONAL GROUP is located in Beijing, China and LA, USA. Now, it has many solely owned and joint stock companies for R&D, manufacturing and marketing. They work for R&D and manufacturing the serial products of life regenerative medicine; marketing skin organ regenerative products and functional skincare products, and improving skin organ regenerative technique; improving regenerative products and techniques of gastrointestinal and pancreas gland tissue organ ect. ; and international trade and techniques cooperation.

MEBO INTERNATIONAL GROUP has good relationships with the academic associations and research institutes in American, British, Germany and Singapore, and maintains stable commercial relationships with MEBO (Thailand) Co., Ltd, MEBO Healthcare Sdn Bhd (Malaysia), Hando Corporation (Korea), Syria UNIPHARMA-M. Adnan Maatouk & CO, Gulf Pharmaceutical Industries (UAE), and Australian Pharmaceuticals Ltd, etc.